Questions? Call 888-624-8373

PREPUB + PDF
your price: $53.00
add to cart

PREPUB
list:$44.95
Web:$40.46
add to cart

PAPERBACK
list:$37.95
Web:$34.16
add to cart

PDF BOOK PREPUB
your price: $34.50
add to cart

PDF CHAPTER PREPUB
your price: $5.20
select

Rights & Permissions

topleft topright

Recognition and Alleviation of Pain in Laboratory Animals (2009)
Institute for Laboratory Animal Research (ILAR)

Page
1
bottomleft bottomright
Page
1

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 1
SUMMARY This report is the response to a request by the New Jersey Association for Biomedical Research that the Institute for Laboratory Animal Research (ILAR) form a consensus committee to update the 1992 National Research Council (NRC) report Recognition and Alleviation of Pain and Distress in Laboratory Animals. This report follows the release of the 2008 National Research Council (NRC) report Recognition and Alleviation of Distress in Laboratory Animals. In the 16 years since the first report was published, there has been significant scientific progress in the areas of animal welfare, stress, distress, and pain to warrant a fresh look at the topics of that report. Although the numerous regulations, policies, and guidelines that govern animal use in research in the United States address distress and pain jointly, from a scientific perspective the two concepts are quite distinct. According to the International Association for the Study of Pain, pain in humans is “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage” (IASP 1979). Pain is mediated through the activity of specialized sensory receptors, called nociceptors, involves the possibility of bodily injury, and depends on the interaction between those nociceptors and higher processing centers in the brain to generate the negative emotional component associated with the potential harm. While pain can be detrimental to animal welfare, distress always is, as it is a measure of the animal’s inability to cope with a stressor. Adopting an approach similar to that taken by the authors of the Recognition and Alleviation of Distress in Laboratory Animals report, this report focuses on the management and avoidance of pain wherever scientifically possible. Continuing in the steps of the 1992 committee, the current committee embraces the idea that in most experimental and husbandry situations laboratory animals need not experience pain, and that its alleviation and prevention are an ethical and moral imperative that is embodied in the relevant regulations and policies. In fact, this approach was codified in the statement of task for this project: “The … report will update information based on the current scientific literature on recognizing and alleviating pain in laboratory animals. The report will discuss the physiology of pain in commonly used laboratory species. Specific emphasis will be placed on the identification of humane endpoints, pharmacologic and non- pharmacologic principles to control pain, and principles to utilize in minimizing pain associated with experimental procedures. As with the Prepublication Copy 1

OCR for page 2
2 SUMMARY first report [on Distress], general guidelines and examples will be given to aid IACUC members, investigators and animal care staff in making decisions about protocols using laboratory animals under current federal regulations and policies”. Approach to this study The committee collected and evaluated scientific evidence from peer- reviewed published literature, evidence-based veterinary practices, and expert opinions. The committee adopted a consistent terminology, defined in the Glossary and Chapter 1, and examined the occurrence of pain in vertebrates alone, for a number of reasons: one, the current regulations affect only the vertebrate phylum; two, the majority of laboratory animal species used in research, education and training are vertebrates; and three, there is ongoing debate about whether pain occurs in subjects that may or may not have consciousness (readers are urged to explore studies from adult humans with persistent vegetative state or dementia and think on the implications of these data for non-verbal populations such as laboratory animals). As it was beyond the task of this committee to evaluate and analyze the last question, the underlying premise of this report is that all vertebrates should be considered capable of experiencing the aversive state of pain. Although most of the information used in the report reflects studies and observations in mammals, currently available, albeit very limited, data on birds, fish, reptiles, and amphibians are also included. The Committee decided against including information on the treatment and management of pain of each laboratory species, because for the commonest of those there are plenty of referenced and peer-reviewed publications, professional societies’ guidelines, books, and book chapters that the audience can easily obtain and refer to. Instead, it opted to expand on those species for which the body of peer-reviewed work is still small and for which guidelines are still lacking. Therefore, the report contains practical information on birds, amphibians, fish, and reptiles in order to help the scientific and veterinary community better care for these laboratory species. Pain in animal research The Committee acknowledges that pain in animals is difficult to access, mostly due to lack of methods that can validate and objectively measure it. Until such tools are developed, behavioral indices and careful extrapolation from the human experience should be used to assess pain in research animals. It should be kept in mind that pain may not only be caused as part of a research procedure, but also may be a by-product of husbandry or other unrelated factors (e.g., aging). Pain may arise not only in response to a Prepublication Copy

OCR for page 3
Recognition and Alleviation of Pain in Laboratory Animals 3 noxious stimulus, but also in situations where increased sensitivity to pain is observed (i.e., hyperlgesia), such as following injury and inflammation. Psychological factors likely contribute to pain under these circumstances. Pain is the result of a cascade of physiological, immunological, cognitive, and behavioral effects that potentially make uncontrolled pain a source of experimental error. Although there are circumstances in which withholding treatment is necessary (as, for example, when pain itself is the focus of the study), routinely withholding analgesics after surgery or other invasive procedures with anticipated moderate to severe pain is detrimental to the welfare of the research subjects and contrary to the regulatory mandate. A useful assumption is that the magnitude of the clinical signs (see Chapter 3) and behavioral changes observed correlates closely with the intensity of pain. Current best practices to assess pain are based on a structured clinical examination combined with solid knowledge of the normal appearance and behavior of the species used. Anticipating the potential intensity of pain is important in designing the most appropriate approach to its management or prevention. Common interventions to treat pain include the use of anesthetics, analgesics, anxiolytics and non-pharmacological methods. It should be noted that, although regulations assert that only non-brief, procedural pain requires treatment, pain of any duration or intensity merits consideration and potential treatment including animals subjected to multiple episodes of momentary pain that may also benefit from measures to alleviate such pain. In a fashion similar to the emphasis stated in Recognition and Alleviation of Distress in Laboratory Animals, the Committee stresses the importance of the Three Rs (replacement, refinement, and reduction) as the standard for identifying, modifying, minimizing and avoiding most causes of pain in laboratory animals. To this end, the Committee believes that adoption of humane endpoints is critical, particularly in those studies where significant pain is anticipated. Because humane endpoints are unique to individual research projects, pilot studies should be undertaken to identify and incorporate them into the study design. Good communication between researchers, veterinarians, animal care personnel and institutional animal care and use committees (IACUCs) is crucial to this process. Recommendations  In light of the information analyzed and discussed in this report, the committee makes overarching consensus recommendations that go above and beyond the recommendations found at the end of individual chapters:  Current scientific evidence strongly suggests that mammals, including rodents (which are the most commonly used laboratory animals), are able to experience pain. Researchers, veterinarians, animal care personnel, and IACUCs should remember the cautionary tone of the Prepublication Copy

OCR for page 4
4 SUMMARY 4th Government Principle1 and use professional judgment and best practices to avoid or minimize unnecessary pain. Studies in which more than momentary pain is anticipated, in addition to providing appropriate analgesia, should also consider and enforce (where possible) humane endpoints to protect the welfare of the laboratory animals.  Knowledge about pain in non-mammalian species is incomplete and in the absence of evidence they should be treated humanely with serious consideration of, and attention to, the potentially painful implications of noxious stimuli and invasive procedures.  Increased efforts should be undertaken to identify appropriate humane endpoints. The importance of pilot studies in this regard cannot be overemphasized. Teamwork and open communication between researchers, veterinarians, animal care staff, and the IACUC can facilitate and expedite this process.  Funding is particularly difficult for projects that investigate the understanding, recognition, and alleviation of pain, especially if the beneficiaries of such projects are the laboratory animals themselves. However, lack of knowledge of drug effects and doses in many mammalian and especially in non-mammalian species, as well as the potentially confounding effects of analgesics and anesthetics on study variables, limit effective pain management. Given the impact of better animal welfare on science as well as the growing public interest in the treatment of laboratory animals, federal agencies and large foundations that support biomedical and behavioral research should make funds available for pain-related studies (see also the recommendations in the Recognition and Alleviation of Distress report, NRC 2008).  Lack of adequate funding also hinders the development and validation of alternatives (methods, procedures, and research strategies), which should be incorporated into research projects and safety assessment tests. Efforts must continue to develop and validate alternatives that can be incorporated into research projects and safety assessment tests. 1 U.S. Government Principle #4 states that: “Proper use of animals, including the avoidance or minimization of discomfort, distress, and pain when consistent with sound scientific practices, is imperative. Unless the contrary is established, investigators should consider that procedures that cause pain or distress in human beings may cause pain or distress in other animals”. Prepublication Copy

OCR for page 5
Recognition and Alleviation of Pain in Laboratory Animals 5  It is necessary to educate investigators, veterinarians and animal care staff as to the basic physiologic principles, causes, signs, and availability of diverse treatment options and potential deleterious effects of those treatments on pain. As the field of pain medicine benefits from new insights and methods of prevention and treatment for humans, so should laboratory animals benefit from the research for which they are a currently indispensable underpinning. By urging laboratory animal veterinarians to understand current pain management, and by suitably updating regulatory policy, the ability to minimize pain in laboratory animals can proceed in tandem with advancing scientific progress. References IASP [International Association for the Study of Pain]. 1979. IASP Pain Terminology. Available at: http://www.iasp- pain.org/AM/Template.cfm?Section=Pain_Deefinitions&Template=/CM/H TMLDisplay.cfm&ContentID=1728#Pain. Accessed January 8 2009. NRC [National Research Council]. 2008. Recognition and Alleviation of Distress in Laboratory Animals. Washington, DC: National Academies Press. Prepublication Copy

OCR for page 6